DiaMedica Therapeutics Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares
DiaMedica Therapeutics Inc. (DMAC) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares of 3.86 million shares as of 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares · last filed 2026-03-30
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares 3.86M shares.
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares 2.37M shares.
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares 1.66M shares.
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares 1.24M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares |
|---|---|
| 2025-12-31 | 3.86M shares 10-K · filed 2026-03-30 |
| 2024-12-31 | 2.37M shares 10-K · filed 2026-03-30 |
| 2023-12-31 | 1.66M shares 10-K · filed 2025-03-17 |
| 2022-12-31 | 1.24M shares 10-K · filed 2024-03-19 |
| 2021-12-31 | 611.72K shares 10-K · filed 2023-03-28 |
| 2020-12-31 | 390.83K shares 10-K · filed 2022-03-14 |
| 2019-12-31 | 578.75K shares 10-K · filed 2021-03-10 |
| 2018-12-31 | 242.33K shares 10-K · filed 2020-03-23 |
| 2017-12-31 | 216.79K shares 10-K · filed 2019-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |